Labcorp Faces Medicare Reform Pressure As Specialty Testing Growth Accelerates!

Laboratory Corporation of America Holdings reported financial results for the first quarter of 2026 showing a moderate improvement in revenue, margins, and earnings per share. The company’s enterprise revenue increased by approximately 6% to $3.5 billion, supported by organic growth, acquisitions, and favorable foreign currency impacts. Adjusted operating margins expanded by over 30 basis points to 14.4%, while adjusted earnings per share rose 11%. Free cash flow generation improved to $71 million compared to a cash outflow in the prior year’s period, albeit the first quarter is typically the company’s weakest for cash flow. Segment performance was mixed but generally positive. The Diagnostics segment reported a 5% revenue increase, with organic revenue up nearly 3%. Volume growth was constrained by adverse weather, which was estimated to negatively impact volume by approximately $15 million.